This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Safety Follow-Up to HP 802-247-09-015

This study has been completed.
Information provided by (Responsible Party):
Healthpoint Identifier:
First received: May 11, 2009
Last updated: September 28, 2016
Last verified: September 2016
The objective of this study is to examine the durability of previous target wound closures, identify new test article-related adverse events, record new target wound closures, and examine ongoing adverse events not resolved in subjects who participated in HP 802-247-09-015.

Venous Leg Ulcer Venous Stasis Ulcer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015

Further study details as provided by Healthpoint:

Primary Outcome Measures:
  • The Number of Participants With Closed Target Ulcers at Each Visit [ Time Frame: Over the 24-week study period, at each of the bi-monthly visits ]
    At each visit the status of closed target ulcers was evaluated as remained closed or re-opened.

  • Number of Subjects With Target Wound Closed for the First Time During the Study Period. [ Time Frame: Over the 24-week study period, at each of the bi-monthly visits ]
    At each visit the status of open target ulcers was evaluated as "remained open" or "closed".

Enrollment: 206
Study Start Date: June 2009
Study Completion Date: January 2012
Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
Safety Follow-Up to HP 802-247-09-015


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects who participated in Study No. 802-247-09-015 - "A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers" and agreed to continue with the follow-up study.


  • Provide informed consent
  • Willing to comply with protocol instructions, including allowing all study assessments.
  • Subject was randomized in HP 802-247-09-015 and received at least one application of a test article, whether active or placebo.
  • Subject has ended their participation in HP 802-247-09-015 by virtue of completing the study, or by dropping out prior to completion.

Exclusion Criteria

  • Subjects who refuse to provide written informed consent will be excluded from this trial.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00900029

  Show 30 Study Locations
Sponsors and Collaborators
Study Director: Hebert B Slade, MD, FAAAAI Healthpoint
  More Information

Responsible Party: Healthpoint Identifier: NCT00900029     History of Changes
Other Study ID Numbers: 802-247-09-016
Study First Received: May 11, 2009
Results First Received: September 28, 2016
Last Updated: September 28, 2016

Keywords provided by Healthpoint:
Venous Leg Ulcer
Venous Stasis Ulcer
Leg Ulcer
Leg Wound

Additional relevant MeSH terms:
Leg Ulcer
Varicose Ulcer
Postphlebitic Syndrome
Postthrombotic Syndrome
Pathologic Processes
Skin Ulcer
Skin Diseases
Varicose Veins
Vascular Diseases
Cardiovascular Diseases
Peripheral Vascular Diseases
Venous Insufficiency
Venous Thrombosis
Embolism and Thrombosis processed this record on July 24, 2017